MedTrace Logo

Clinical Study Evaluating the Efficacy and Safety of CID v2.2 in Glaucoma Surgery

NCT05625958 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2026-04-22

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and effectiveness of implanting a new version of an interposition supraciliary implant (SV22) as a stand-alone therapy for lowering intraocular pressure (IOP) in patients with primary open and narrow angle glaucoma who have failed at least one class of topical medical therapy

Conditions

  • Glaucoma, Open-Angle
  • Glaucoma, Narrow Angle

Interventions

DEVICE

Cilioscleral Interposition Device

Surgical placement of SV22 cilioscleral interposition device in the supraciliary space

Sponsors & Collaborators

  • Ciliatech

    lead INDUSTRY

Principal Investigators

  • Julian GARCIA FEIJOO, Pr · Clinica San Carlos

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-23
Primary Completion
2026-04-29
Completion
2028-09-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05625958 on ClinicalTrials.gov